{"PubmedArticle": [{"MedlineCitation": {"CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "InvestigatorList": [], "OtherID": [], "OtherAbstract": [], "SpaceFlightMission": [], "PMID": "4108367", "DateCompleted": {"Year": "1972", "Month": "02", "Day": "21"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "30"}, "Article": {"Language": ["ger"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0005-9498", "JournalIssue": {"Volume": "18", "Issue": "3", "PubDate": {"Year": "1970", "Month": "Jun"}}, "Title": "Berufs-Dermatosen", "ISOAbbreviation": "Berufsdermatosen"}, "ArticleTitle": "[Protracted chemical burns (with special reference to skin damages caused by epoxides and propansultone)].", "Pagination": {"StartPage": "144", "EndPage": "165", "MedlinePgn": "144-65"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Ippen", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Mathies", "ForeName": "V", "Initials": "V"}], "PublicationTypeList": ["Journal Article"], "VernacularTitle": "Die \"protrahierte Ver\u00e4tzung\" (unter besonderer Ber\u00fccksichtigung der Hautsch\u00e4den durch Epoxide und Propansulton."}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Berufsdermatosen", "NlmUniqueID": "0372506", "ISSNLinking": "0005-9498"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Adrenal Cortex Hormones"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents, Local"}, {"RegistryNumber": "0", "NameOfSubstance": "Carbonates"}, {"RegistryNumber": "0", "NameOfSubstance": "Chlorides"}, {"RegistryNumber": "0", "NameOfSubstance": "Esters"}, {"RegistryNumber": "0", "NameOfSubstance": "Ethers, Cyclic"}, {"RegistryNumber": "0", "NameOfSubstance": "Heparinoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Heterocyclic Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Penicillins"}, {"RegistryNumber": "0", "NameOfSubstance": "Pyridines"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfonic Acids"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "1405-87-4", "NameOfSubstance": "Bacitracin"}, {"RegistryNumber": "451W47IQ8X", "NameOfSubstance": "Sodium Chloride"}, {"RegistryNumber": "9NEZ333N27", "NameOfSubstance": "Sodium"}, {"RegistryNumber": "I16QD7X297", "NameOfSubstance": "Neomycin"}, {"RegistryNumber": "KVI301NA53", "NameOfSubstance": "Pyridostigmine Bromide"}, {"RegistryNumber": "N9YNS0M02X", "NameOfSubstance": "Acetylcholine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Accidents, Occupational"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Acetylcholine"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Adrenal Cortex Hormones"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Anti-Infective Agents, Local"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Bacitracin"}, {"QualifierName": ["diagnosis", "drug therapy", "etiology", "prevention & control", "therapy"], "DescriptorName": "Burns, Chemical"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Carbonates"}, {"QualifierName": [], "DescriptorName": "Chemical Industry"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Chlorides"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Esters"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Ethers, Cyclic"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Exanthema"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Heparinoids"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Heterocyclic Compounds"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Neomycin"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Occupational Diseases"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Penicillins"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Pyridines"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Pyridostigmine Bromide"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Sodium"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Sodium Chloride"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Sulfonic Acids"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Vasodilator Agents"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1970", "Month": "6", "Day": "1"}, {"Year": "1970", "Month": "6", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1970", "Month": "6", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["4108367"]}}], "PubmedBookArticle": []}